Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics of COPD.

Néstor A Molfino1

  • 1Otsuka Maryland Research Institute, Rockville, MD 20850, USA. nestorm@otsuka.com

Chest
|May 12, 2004
PubMed
Summary
This summary is machine-generated.

Genetic factors influence the risk of developing Chronic Obstructive Pulmonary Disease (COPD), a major cause of death. Understanding these genetic predispositions is key to future COPD treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics.

Advances in therapy·2026
Same author

AZD8630/AMG 104, an inhaled anti-thymic stromal lymphopoietin antibody fragment, for moderate-to-severe asthma: Phase 1 randomized controlled trial.

The Journal of allergy and clinical immunology·2026
Same author

INSIGHTS Asthma Pragmatic Registry - A Pragmatic Approach to High-Validity Real-World Evidence for Asthma.

Pragmatic and observational research·2025
Same author

Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study.

The journal of allergy and clinical immunology. In practice·2025
Same author

Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies.

Pulmonary therapy·2025
Same author

Tezepelumab for the treatment of chronic spontaneous urticaria: Results of the phase 2b INCEPTION study.

The Journal of allergy and clinical immunology·2025

Area of Science:

  • Pulmonary Medicine
  • Genetics
  • Molecular Biology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) encompasses chronic bronchitis and emphysema, often linked to smoking but with non-smoker cases and unknown molecular drivers.
  • COPD is a significant cause of mortality in the US, yet effective disease-modifying therapies are lacking.
  • Current understanding of COPD's molecular mechanisms and genetic underpinnings remains limited.

Purpose of the Study:

  • To review the genetic predisposition in individuals susceptible to developing COPD.
  • To discuss the genetic basis for COPD characterized by rapid decline in FEV1 (Forced Expiratory Volume in 1 second).
  • To synthesize current genetic data from COPD patient studies focusing on emphysema, chronic bronchitis, and bronchodilator response phenotypes.

Main Methods:

Related Experiment Videos

  • Review of existing literature on genetic association studies and linkage analyses in COPD patients.
  • Analysis of genetic data stratified by COPD phenotypes (emphysema, chronic bronchitis) and clinical response (FEV1 decline, bronchodilator responsiveness).
  • Examination of genetic predisposition in healthy individuals and relatives of COPD patients.

Main Results:

  • Genetic factors contribute to COPD susceptibility, even in non-smokers.
  • Specific genetic bases are being identified for COPD with rapid FEV1 decline.
  • Genetic data reveal distinct patterns related to emphysema and chronic bronchitis phenotypes.

Conclusions:

  • Genetic predisposition plays a crucial role in COPD development and progression.
  • Further research into the genetic architecture of COPD is essential for therapeutic development.
  • Understanding genetic variations can help identify individuals at risk and tailor treatment strategies.